Journal
BIOMEDICINES
Volume 11, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines11010089
Keywords
complex regional pain syndrome; chronic limb pain; nociplastic pain; psychological state; cluster analysis; CRPS clinical phenotypes
Ask authors/readers for more resources
Through cluster analysis of 61 chronic CRPS and 31 CLP patients, three clinical phenotypes were identified: 'CRPS', 'CLP', and 'Mixed'. These groups differed in pain sensitivity and psychological state, particularly in evoked pain. This study provides important evidence for the diagnosis of CRPS and its subtypes, with TNF-alpha identified as a potential biomarker.
Complex regional pain syndrome (CRPS) taxonomy has been updated with reported subtypes and is defined as primary pain alongside other chronic limb pain (CLP) conditions. We aimed at identifying CRPS clinical phenotypes that distinguish CRPS from other CLP conditions. Cluster analysis was carried out to classify 61 chronic CRPS and 31 CLP patients based on evoked pain (intensity of hyperalgesia and dynamic allodynia, allodynia area, and after-sensation) and psychological (depression, kinesiophobia, mental distress, and depersonalization) measures. Pro-inflammatory cytokine IL-6 and TNF-alpha serum levels were measured. Three cluster groups were created: 'CRPS' (78.7% CRPS; 6.5% CLP); 'CLP' (64.5% CLP; 4.9% CRPS), and 'Mixed' (16.4% CRPS; 29% CLP). The groups differed in all measures, predominantly in allodynia and hyperalgesia (p < 0.001, eta(2) > 0.58). 'CRPS' demonstrated higher psychological and evoked pain measures vs. 'CLP'. 'Mixed' exhibited similarities to 'CRPS' in psychological profile and to 'CLP' in evoked pain measures. The serum level of TNF-alpha was higher in the 'CRPS' vs. 'CLP' (p < 0.001) groups. In conclusion, pain hypersensitivity reflecting nociplastic pain mechanisms and psychological state measures created different clinical phenotypes of CRPS and possible CRPS subtypes, which distinguishes them from other CLP conditions, with the pro-inflammatory TNF-alpha cytokine as an additional potential biomarker.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available